Developing technologies for personalised treatment

Development and expansion of the IFOM-IEO campus

Histology and non-histology driven therapy for soft tissue sarcomas and the Rare Cancers Europe initiative

Improving health outcomes around the world

Translational and tailored, but can we afford it?

Translational and tailored, but can we afford it?

The changing field of drug development

Important to support young medical oncologists’ research

The WINTHER study

Drugging the cancer genome: opportunities and challenges

Introduction of PET tracers to the WINTHER trial

EurocanPlatform project update